145 related articles for article (PubMed ID: 19126215)
1. Does doxycycline work in synergy with cisplatin and oxaliplatin in colorectal cancer?
Sagar J; Sales K; Dijk S; Taanman J; Seifalian A; Winslet M
World J Surg Oncol; 2009 Jan; 7():2. PubMed ID: 19126215
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin enhanced the antitumor efficacy of oxaliplatin in cisplatin-resistant ovarian cancer cells A2780cis both in vitro and in vivo.
Liu J; Zhang L; Zhang X; Xing X
J Chemother; 2015; 27(6):358-64. PubMed ID: 25976336
[TBL] [Abstract][Full Text] [Related]
3. EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells.
Hu F; Wei F; Wang Y; Wu B; Fang Y; Xiong B
J Pharmacol Sci; 2015 May; 128(1):27-34. PubMed ID: 26003085
[TBL] [Abstract][Full Text] [Related]
4. Lowering the apoptotic threshold in colorectal cancer cells by targeting mitochondria.
Sagar J; Sales K; Taanman JW; Dijk S; Winslet M
Cancer Cell Int; 2010 Sep; 10():31. PubMed ID: 20819205
[TBL] [Abstract][Full Text] [Related]
5. Superior cytotoxicity and DNA cross-link induction by oxaliplatin versus cisplatin at lower cellular uptake in colorectal cancer cell lines.
Virag P; Perde-Schrepler M; Fischer-Fodor E; Tatomir C; Dorneanu SA; Cernea VI; Irimie A
Anticancer Drugs; 2012 Nov; 23(10):1032-8. PubMed ID: 22614106
[TBL] [Abstract][Full Text] [Related]
6. Review of oxaliplatin: an active platinum agent in colorectal cancer.
Cassidy J
Int J Clin Pract; 2000; 54(6):399-402. PubMed ID: 11092115
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells.
Fiore D; Proto MC; Pisanti S; Picardi P; Pagano Zottola AC; Butini S; Gemma S; Casagni A; Laezza C; Vitale M; Ligresti A; Di Marzo V; Zisterer DM; Nathwani S; Williams DC; Campiani G; Gazzerro P; Bifulco M
Cancer Biol Ther; 2016 Aug; 17(8):849-58. PubMed ID: 26392056
[TBL] [Abstract][Full Text] [Related]
8. Cellular uptake and cytoplasm / DNA distribution of cisplatin and oxaliplatin and their liposomal formulation in human colorectal cancer cell HCT116.
Tippayamontri T; Kotb R; Paquette B; Sanche L
Invest New Drugs; 2011 Dec; 29(6):1321-7. PubMed ID: 20658169
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.
Kitada N; Takara K; Minegaki T; Itoh C; Tsujimoto M; Sakaeda T; Yokoyama T
Cancer Chemother Pharmacol; 2008 Sep; 62(4):577-84. PubMed ID: 18030470
[TBL] [Abstract][Full Text] [Related]
10. Treatment schedule-dependent effect of 5-fluorouracil and platinum derivatives in colorectal cancer cells.
Takara K; Fujita M; Minegaki T; Yamamoto K; Takahashi M; Yokoyama T; Okumura K
Eur J Pharm Sci; 2012 Feb; 45(3):272-81. PubMed ID: 22155546
[TBL] [Abstract][Full Text] [Related]
11. Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance.
Zhang Y; Huang L; Shi H; Chen H; Tao J; Shen R; Wang T
Cancer Sci; 2018 Jan; 109(1):94-102. PubMed ID: 29034540
[TBL] [Abstract][Full Text] [Related]
12. Current status of oxaliplatin in colorectal cancer.
O'Dwyer PJ; Johnson SW
Semin Oncol; 2003 Jun; 30(3 Suppl 6):78-87. PubMed ID: 12802798
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.
Meynard D; Le Morvan V; Bonnet J; Robert J
Oncol Rep; 2007 May; 17(5):1213-21. PubMed ID: 17390068
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin: a novel platinum analog with activity in colorectal cancer.
Berg D
Oncol Nurs Forum; 2003; 30(6):957-66. PubMed ID: 14603353
[TBL] [Abstract][Full Text] [Related]
15. Synergism in concomitant chemoradiotherapy of cisplatin and oxaliplatin and their liposomal formulation in the human colorectal cancer HCT116 model.
Tippayamontri T; Kotb R; Paquette B; Sanche L
Anticancer Res; 2012 Oct; 32(10):4395-404. PubMed ID: 23060564
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin (L-OHP): a new reality in colorectal cancer.
Bleiberg H
Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):1-3. PubMed ID: 9647611
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles Loaded with Platinum Drugs for Colorectal Cancer Therapy.
Buyana B; Naki T; Alven S; Aderibigbe BA
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232561
[TBL] [Abstract][Full Text] [Related]
18. Melatonin Promotes Apoptosis of Oxaliplatin-resistant Colorectal Cancer Cells Through Inhibition of Cellular Prion Protein.
Lee JH; Yoon YM; Han YS; Yun CW; Lee SH
Anticancer Res; 2018 Apr; 38(4):1993-2000. PubMed ID: 29599315
[TBL] [Abstract][Full Text] [Related]
19. Platinum compounds in the treatment of advanced breast cancer.
MartÃn M
Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.
Culy CR; Clemett D; Wiseman LR
Drugs; 2000 Oct; 60(4):895-924. PubMed ID: 11085200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
